Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6190

1.

Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.

Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D.

Neuropsychopharmacology. 2019 Mar 16. doi: 10.1038/s41386-019-0371-2. [Epub ahead of print]

PMID:
30879021
2.

Break the net, break the cycle: removal of perineuronal nets in the lateral hypothalamus decreases cocaine relapse.

Marchant NJ.

Neuropsychopharmacology. 2019 Apr;44(5):835-836. doi: 10.1038/s41386-018-0245-z. Epub 2018 Oct 24. No abstract available.

PMID:
30867569
3.

Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial.

Coenen VA, Bewernick BH, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein ME, Spanier S, Sajonz B, Urbach H, Schlaepfer TE.

Neuropsychopharmacology. 2019 Mar 13. doi: 10.1038/s41386-019-0369-9. [Epub ahead of print]

PMID:
30867553
4.

Multimodal neurocognitive markers of interoceptive tuning in smoked cocaine.

de la Fuente A, Sedeño L, Vignaga SS, Ellmann C, Sonzogni S, Belluscio L, García-Cordero I, Castagnaro E, Boano M, Cetkovich M, Torralva T, Cánepa ET, Tagliazucchi E, Garcia AM, Ibañez A.

Neuropsychopharmacology. 2019 Mar 13. doi: 10.1038/s41386-019-0370-3. [Epub ahead of print]

PMID:
30867552
5.

Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Johansson J, Hirvonen J, Lovró Z, Ekblad L, Kaasinen V, Rajasilta O, Helin S, Tuisku J, Sirén S, Pennanen M, Agrawal A, Crystal R, Vainio PJ, Alho H, Scheinin M.

Neuropsychopharmacology. 2019 Mar 13. doi: 10.1038/s41386-019-0368-x. [Epub ahead of print]

PMID:
30867551
6.

Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stress.

Zhu X, Nedelcovych MT, Thomas AG, Hasegawa Y, Moreno-Megui A, Coomer W, Vohra V, Saito A, Perez G, Wu Y, Alt J, Prchalova E, Tenora L, Majer P, Rais R, Rojas C, Slusher BS, Kamiya A.

Neuropsychopharmacology. 2019 Mar 13. doi: 10.1038/s41386-019-0354-3. [Epub ahead of print]

PMID:
30862949
7.

Ting-Kai Li, M.D.

Goldman D.

Neuropsychopharmacology. 2019 Mar 11. doi: 10.1038/s41386-019-0358-z. [Epub ahead of print] No abstract available.

PMID:
30858534
8.

Correction: Striato-cortical tracts predict 12-h abstinence-induced lapse in smokers.

Yuan K, Zhao M, Yu D, Manza P, Volkow ND, Wang GJ, Tian J.

Neuropsychopharmacology. 2019 Mar 12. doi: 10.1038/s41386-019-0330-y. [Epub ahead of print]

PMID:
30858533
9.

Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.

Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Wade E, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, Murrough JW.

Neuropsychopharmacology. 2019 Mar 11. doi: 10.1038/s41386-019-0365-0. [Epub ahead of print]

PMID:
30858518
10.

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders.

Newman AH, Cao J, Keighron JD, Jordan CJ, Bi GH, Liang Y, Abramyan AM, Avelar AJ, Tschumi CW, Beckstead MJ, Shi L, Tanda G, Xi ZX.

Neuropsychopharmacology. 2019 Mar 11. doi: 10.1038/s41386-019-0366-z. [Epub ahead of print]

PMID:
30858517
11.

Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.

Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C, Erritzoe D, Ozenne B, Knudsen GM.

Neuropsychopharmacology. 2019 Mar 8. doi: 10.1038/s41386-019-0360-5. [Epub ahead of print]

PMID:
30846853
12.

In memoriam: Conan Kornetsky, B.A., D.Phil., M.A.

Jaffe JH, Meyer RE.

Neuropsychopharmacology. 2019 Mar 7. doi: 10.1038/s41386-019-0352-5. [Epub ahead of print] No abstract available.

PMID:
30846852
13.

Lewis Judd, M.D.

Grant I, Braff D.

Neuropsychopharmacology. 2019 Mar 7. doi: 10.1038/s41386-019-0359-y. [Epub ahead of print] No abstract available.

PMID:
30846851
14.

Altered anticipation and processing of aversive interoceptive experience among women remitted from bulimia nervosa.

Berner LA, Simmons AN, Wierenga CE, Bischoff-Grethe A, Paulus MP, Bailer UF, Kaye WH.

Neuropsychopharmacology. 2019 Mar 6. doi: 10.1038/s41386-019-0361-4. [Epub ahead of print]

PMID:
30840983
15.

Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.

Leucht S, Barabássy Á, Laszlovszky I, Szatmári B, Acsai K, Szalai E, Harsányi J, Earley W, Németh G.

Neuropsychopharmacology. 2019 Mar 5. doi: 10.1038/s41386-019-0363-2. [Epub ahead of print]

PMID:
30836381
16.

Women using hormonal contraceptives show increased valence ratings and memory performance for emotional information.

Spalek K, Loos E, Schicktanz N, Hartmann F, de Quervain D, Stier C, Milnik A.

Neuropsychopharmacology. 2019 Mar 5. doi: 10.1038/s41386-019-0362-3. [Epub ahead of print]

PMID:
30836380
17.

Buzzkill: the consequences of depleting anandamide in the hippocampus.

Morena M, Hill MN.

Neuropsychopharmacology. 2019 Mar 1. doi: 10.1038/s41386-019-0357-0. [Epub ahead of print] No abstract available.

PMID:
30824852
18.

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia.

Bitter I, Lieberman JA, Gaudoux F, Sokoloff P, Groc M, Chavda R, Delsol C, Barthe L, Brunner V, Fabre C, Fagard M, Montagne A, Tonner F.

Neuropsychopharmacology. 2019 Mar 1. doi: 10.1038/s41386-019-0355-2. [Epub ahead of print]

PMID:
30822774
19.

Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats.

Townsend EA, Negus SS, Caine SB, Thomsen M, Banks ML.

Neuropsychopharmacology. 2019 Feb 28. doi: 10.1038/s41386-019-0356-1. [Epub ahead of print]

PMID:
30818323
20.

Reduced focal fiber collinearity in the cingulum bundle in adults with obsessive-compulsive disorder.

Versace A, Graur S, Greenberg T, Lima Santos JP, Chase HW, Bonar L, Stiffler RS, Hudak R, Kim T, Yendiki A, Greenberg B, Rasmussen S, Liu H, Haber S, Phillips ML.

Neuropsychopharmacology. 2019 Feb 25. doi: 10.1038/s41386-019-0353-4. [Epub ahead of print] Review.

PMID:
30802896

Supplemental Content

Loading ...
Support Center